CONSOLIDATED STATEMENT OF STOCKHOLDERS’ EQUITY - USD ($) shares in Thousands, $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Retained Earnings	Accumulated Other Comprehensive Income/(Loss)
Balance, shares (in shares) at Apr. 01, 2017		52,255
Balance, value at Apr. 01, 2017	$ 739,610	$ 523	$ 482,044	$ 289,916	$ (32,873)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Employee stock purchase plan (in shares)		102
Employee stock purchase plan	3,246	$ 1	3,245
Exercise of stock options (in shares)		1,014
Exercise of stock options	37,094	$ 11	37,083
Shares repurchased (in shares)		(1,162)
Shares repurchased	(100,000)	$ (12)	(31,442)	(68,546)
Issuance of restricted stock, net of cancellations (in shares)		134
Issuance of restricted stock, net of cancellations	0
Share-based compensation expense	13,025		13,025
Net income	45,572			45,572
Other comprehensive income (loss)	13,882				13,882
Balance, shares (in shares) at Mar. 31, 2018		52,343
Balance, value at Mar. 31, 2018	752,429	$ 523	503,955	266,942	(18,991)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Employee stock purchase plan (in shares)		67
Employee stock purchase plan	3,254	$ 1	3,253
Exercise of stock options (in shares)		287
Exercise of stock options	10,191	$ 3	10,188
Shares repurchased (in shares)		(1,841)
Shares repurchased	(160,000)	$ (18)	1,737	(161,719)
Issuance of restricted stock, net of cancellations (in shares)		164
Issuance of restricted stock, net of cancellations	0	$ 1	(1)
Share-based compensation expense	17,188		17,188
Net income	55,019			55,019
Other comprehensive income (loss)	(11,389)				(11,389)
Balance, shares (in shares) at Mar. 30, 2019		51,020
Balance, value at Mar. 30, 2019	667,868	$ 510	536,320	161,418	(30,380)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Employee stock purchase plan (in shares)		45
Employee stock purchase plan	3,369	$ 1	3,368
Exercise of stock options (in shares)		232
Exercise of stock options	8,647	$ 2	8,645
Shares repurchased (in shares)		(1,483)
Shares repurchased	(175,000)	$ (15)	(15,553)	(159,432)
Issuance of restricted stock, net of cancellations (in shares)		509
Issuance of restricted stock, net of cancellations	0	$ 5	(5)
Share-based compensation expense	20,454		20,454
Net income	76,526			76,526
Other comprehensive income (loss)	(14,755)				(14,755)
Balance, shares (in shares) at Mar. 28, 2020		50,323
Balance, value at Mar. 28, 2020	$ 587,109	$ 503	$ 553,229	$ 78,512	$ (45,135)